Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick G Strathmann

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Clinical Chemistry|March 8, 2016
N-of-1 Clinical Trials: Removing the Hay to Find the NeedleFrederick G Strathmann
Clinical Biochemistry|March 19, 2024
Retraction notice to "Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing" [Clin. Biochem. 82 (2020) 85-89]Rebecca Mastrovito, Frederick G Strathmann
Pain Medicine (Malden, Mass.)|February 17, 2017
Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing StrategyKelly Doyle, Frederick G Strathmann
Clinical Biochemistry|March 7, 2020
Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testingRebecca Mastrovito, Frederick G Strathmann
Journal of Analytical Toxicology|July 12, 2013
Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMITChia-Ni Lin, Frederick G Strathmann
Clinics in Laboratory Medicine|January 22, 2013
Patient data algorithmsJoely A Straseski, Frederick G Strathmann
American Journal of Clinical Pathology|September 16, 2011
Current and future applications of mass spectrometry to the clinical laboratoryFrederick G Strathmann, Andrew N Hoofnagle
American Journal of Clinical Pathology|July 13, 2014
Total arsenic screening prior to fractionation enhances clinical utility and test utilization in the assessment of arsenic toxicitySarah A Hackenmueller, Frederick G Strathmann
Clinical Biochemistry|December 3, 2014
Simplified sample preparation in the simultaneous measurement of whole blood antimony, bismuth, manganese, and zinc by inductively coupled plasma mass spectrometryCarrie J Haglock-Adler, Frederick G Strathmann
The Journal of Applied Laboratory Medicine|February 27, 2021
Lowering the Bar for Mass Spectrometry: A Comparison between Immunoassay and Rapid Time-of-Flight for Presumptive Screening of Drugs in UrineNatalie N Rasmussen, Adam Barker, Frederick G Strathmann
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|March 8, 2016
N-of-1 Clinical Trials: Removing the Hay to Find the NeedleFrederick G Strathmann
Clinical Biochemistry|March 19, 2024
Retraction notice to "Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testing" [Clin. Biochem. 82 (2020) 85-89]Rebecca Mastrovito, Frederick G Strathmann
Pain Medicine (Malden, Mass.)|February 17, 2017
Cost and Efficacy Assessment of an Alternative Medication Compliance Urine Drug Testing StrategyKelly Doyle, Frederick G Strathmann
Clinical Biochemistry|March 7, 2020
Distributions of alcohol use biomarkers including ethanol, phosphatidylethanol, ethyl glucuronide and ethyl sulfate in clinical and forensic testingRebecca Mastrovito, Frederick G Strathmann
Journal of Analytical Toxicology|July 12, 2013
Elevated urine zinc concentration reduces the detection of methamphetamine, cocaine, THC and opiates in urine by EMITChia-Ni Lin, Frederick G Strathmann
Clinics in Laboratory Medicine|January 22, 2013
Patient data algorithmsJoely A Straseski, Frederick G Strathmann
American Journal of Clinical Pathology|September 16, 2011
Current and future applications of mass spectrometry to the clinical laboratoryFrederick G Strathmann, Andrew N Hoofnagle
American Journal of Clinical Pathology|July 13, 2014
Total arsenic screening prior to fractionation enhances clinical utility and test utilization in the assessment of arsenic toxicitySarah A Hackenmueller, Frederick G Strathmann
Clinical Biochemistry|December 3, 2014
Simplified sample preparation in the simultaneous measurement of whole blood antimony, bismuth, manganese, and zinc by inductively coupled plasma mass spectrometryCarrie J Haglock-Adler, Frederick G Strathmann
The Journal of Applied Laboratory Medicine|February 27, 2021
Lowering the Bar for Mass Spectrometry: A Comparison between Immunoassay and Rapid Time-of-Flight for Presumptive Screening of Drugs in UrineNatalie N Rasmussen, Adam Barker, Frederick G Strathmann
Pageof 6